药易购 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	4.4B	4.4B	4.0B	3.4B	2.8B
Revenue Growth %	-1.1%	11.6%	16.7%	21.9%	--
Total Revenue	4.4B	4.4B	4.0B	3.4B	2.8B
Cost Of Revenue	4.0B	4.1B	3.7B	3.2B	2.6B
+Gross Profit	390.0M	367.0M	315.0M	186.0M	198.0M
Gross Margin %	8.9%	8.3%	7.9%	5.5%	7.1%
Total Operating Cost	4.4B	4.4B	3.9B	3.4B	2.7B
Selling Expenses	251.0M	191.0M	162.0M	129.0M	102.0M
Admin Expenses	71.0M	57.5M	59.6M	35.5M	23.2M
Rd Expenses	15.5M	19.3M	17.7M	11.4M	--
Finance Expenses	8.9M	7.0M	7.3M	2.2M	3.3M
+Operating Income	16.4M	68.6M	47.2M	9.3M	61.2M
Operating Margin %	0.4%	1.5%	1.2%	0.3%	2.2%
Non Operating Income	2.1M	1.7M	168,300	18,700	1.8M
Non Operating Expenses	1.3M	371,500	2.5M	1.2M	1.1M
Investment Income	-1.8M	1.5M	-4.3M	7.5M	177,000
Asset Disposal Income	-606,300	-52,700	-79,200	-108,600	-60,000
Asset Impairment Loss	9.9M	9.1M	8.4M	4.3M	3.9M
Other Income	2.0M	3.7M	9.4M	5.8M	2.0M
Income Before Tax	17.2M	69.9M	44.9M	8.1M	61.8M
Income Tax	1.8M	13.1M	8.8M	1.4M	9.4M
+Net Income	15.4M	56.8M	36.1M	6.7M	52.4M
Net Margin %	0.4%	1.3%	0.9%	0.2%	1.9%
Net Income Attributable	16.4M	59.5M	42.0M	6.4M	54.0M
Minority Interest	-958,300	-2.8M	-5.9M	329,000	-1.6M
Eps Basic	0.17	0.62	0.44	0.07	0.75
Eps Diluted	0.17	0.62	0.44	0.07	0.75

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	387.0M	375.0M	458.0M	154.0M	114.0M
Trading Financial Assets	1.5M	4.0M	7.0M	--	--
Accounts Receivable	185.0M	123.0M	69.3M	27.5M	26.9M
Notes Receivable	3.8M	--	1.1M	6.1M	--
Notes And Accounts Receivable	189.0M	123.0M	70.5M	33.6M	26.9M
Prepayments	131.0M	164.0M	186.0M	123.0M	82.7M
Inventory	517.0M	561.0M	447.0M	468.0M	338.0M
Total Current Assets	1.4B	1.4B	1.3B	832.0M	609.0M
Long Term Equity Investment	15.9M	10.8M	5.4M	3.4M	2.1M
Fixed Assets	--	142.0M	155.0M	164.0M	144.0M
Fixed Assets Total	144.0M	142.0M	155.0M	164.0M	144.0M
Construction In Progress	--	2.2M	1.8M	--	19.6M
Construction In Progress Total	504,400	2.2M	1.8M	--	19.6M
Intangible Assets	47.6M	46.4M	50.7M	42.1M	39.2M
Long Term Deferred Expenses	12.9M	20.4M	4.0M	5.3M	4.1M
Total Non Current Assets	331.0M	311.0M	328.0M	355.0M	230.0M
Total Assets	1.7B	1.7B	1.6B	1.2B	839.0M
Short Term Borrowings	372.0M	321.0M	236.0M	119.0M	40.0M
Accounts Payable	236.0M	211.0M	186.0M	129.0M	118.0M
Advance Receipts	--	--	--	--	--
Contract Liabilities	49.8M	53.6M	78.8M	29.8M	21.0M
Total Current Liabilities	838.0M	801.0M	753.0M	378.0M	298.0M
Total Non Current Liabilities	27.9M	29.9M	18.9M	21.1M	16.0M
Total Liabilities	866.0M	831.0M	772.0M	399.0M	314.0M
Paid In Capital	95.7M	95.7M	95.7M	95.7M	71.8M
Capital Reserve	474.0M	474.0M	476.0M	476.0M	231.0M
Surplus Reserve	42.3M	39.1M	33.0M	27.7M	26.5M
Retained Earnings	238.0M	245.0M	211.0M	175.0M	188.0M
Minority Equity	1.2M	1.8M	6.0M	14.4M	7.2M
Equity Attributable	850.0M	854.0M	814.0M	774.0M	518.0M
Total Equity	851.0M	856.0M	820.0M	788.0M	525.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	4.1B	4.2B	3.8B	3.9B	2.7B
Tax Refunds Received	656,200	88,800	--	--	--
Total Operating Cash Inflow	4.1B	4.2B	3.8B	3.9B	2.7B
Cash Paid For Goods	3.5B	4.0B	3.4B	3.8B	2.5B
Cash Paid To Employees	160.0M	151.0M	131.0M	101.0M	76.5M
Taxes Paid	58.7M	65.4M	44.4M	30.8M	41.7M
Total Operating Cash Outflow	4.0B	4.3B	3.7B	4.0B	2.7B
Operating Cash Flow	128.0M	-115.0M	153.0M	-154.0M	69.3M
Total Investing Cash Inflow	121.0M	18.2M	22.8M	2.6M	7.0M
Total Investing Cash Outflow	170.0M	153.0M	33.2M	134.0M	37.7M
Investing Cash Flow	-49.6M	-135.0M	-10.4M	-132.0M	-30.7M
Cash From Borrowings	457.0M	331.0M	185.0M	130.0M	40.0M
Dividends And Interest Paid	30.3M	24.9M	5.3M	20.7M	12.6M
Debt Repayments	454.0M	195.0M	119.0M	51.0M	40.0M
Total Financing Cash Inflow	458.0M	335.0M	188.0M	419.0M	40.3M
Total Financing Cash Outflow	493.0M	227.0M	130.0M	92.1M	52.6M
Financing Cash Flow	-34.9M	107.0M	57.2M	327.0M	-12.3M
Net Change In Cash	43.2M	-143.0M	199.0M	40.5M	26.3M
Ending Cash Balance	235.0M	191.0M	335.0M	135.0M	94.6M
Capex	32.2M	35.3M	18.3M	31.4M	35.2M